Sagility Limited (NSE: SAGILITY) reports 27.3% Y-o-Y organic growth in Q1 FY27, wins $35.3M ACV, and acquires CareSeed.
Anthem Biosciences Limited (NSE: ANTHEM) investor presentation highlights strong Q1FY27 performance with robust margins and promising future outlook.
Granules India Limited (GRANULES) reports Q1 FY27 results with revenue up 22% YoY, EBITDA up 37%, and PAT up 60%.
Glenmark Pharmaceuticals Limited (GLENMARK) secures U.S. FDA approval to expand RYALTRIS® use for children aged 6 to less than 12 years.
Emcure Pharmaceuticals Limited (EMCURE) expands Poviztra® for MASH treatment, addressing unmet medical needs for metabolic dysfunction-associated steatohepat.
Torrent Pharmaceuticals Limited (TORNTPHARM) stock breaks out, rising 5% intraday to ₹5014.0, surpassing its 6M resistance trendline at ₹4693.
Vimta Labs Limited (VIMTALABS) reports Q1 FY27 results with total income up 13.7% YoY, EBITDA margin at 36.4%, and PAT margin at 18.6%.
Fortis Healthcare Limited (FORTIS) announces the appointment of Vijender Singh as Managing Director & CEO of Agilus Diagnostics, a key subsidiary.
Metropolis Healthcare Limited (NSE: METROPOLIS) stock moves up 5% intraday to ₹574.15, successfully clearing resistance at ₹550.
Thyrocare Technologies Limited (NSE: THYROCARE) stock moves up 5% intraday to ₹550.3, showing a bounce despite a breakdown trendline status.